AlzeCure Pharma
Clinical-stage pharma developing drugs for CNS diseases like Alzheimer's and pain.
ALZCUR | ST
Overview
Corporate Details
- ISIN(s):
- SE0010133785 (+1 more)
- LEI:
- 5493001EJLEBXFY6I446
- Country:
- Sweden
- Address:
- Hälsovägen 7, 141 57 Huddinge
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
AlzeCure Pharma is a clinical-stage pharmaceutical company focused on the research and development of innovative small-molecule drug therapies. The company's primary focus is on severe diseases affecting the central nervous system, particularly Alzheimer's disease and pain. Its R&D strategy is based on three proprietary platforms designed to develop a portfolio of symptomatic, disease-modifying, and preventive treatments. Key projects include the NeuroRestore candidate, ACD856, which is advancing into Phase 2 clinical trials for Alzheimer's disease.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for AlzeCure Pharma and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all AlzeCure Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for AlzeCure Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
